United States Biotechnology & Medical Research

Cullinan Therapeutics Inc (CGEM)

Track

Track

Cullinan Therapeutics Inc. experienced significant insider trading activity recently, characterized by multiple planned sales from Chief Scientific Officer Jennifer Michaelson. These divestments totaled over 1.6 million dollars. The stock has demonstrated strong momentum, rising 39.4% over the last quarter, despite a recent earnings report showing a 14.08% miss on expected per-share performance.
Ticker: CGEM Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cullinan Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
452.08
Quantity 14,613 -1.3%
Value US$4,541,010
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
358.87
Quantity 32,417
Value US$1,892,626
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
205.72
Quantity 11,895 +34.6%
Value US$3,757,278
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.82
Quantity 8,000 -4.7%
Value US$142,560
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
17.63
Quantity 8,000
Value US$141,040
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.58
Quantity 200 -0.1%
Value US$3,116
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
14.60
Quantity 7,800 -4.5%
Value US$113,880
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
15.34
Quantity 8,000
Value US$122,720
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.68
Quantity 8,000 -4.5%
Value US$125,440
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
16.30
Quantity 8,000
Value US$130,400
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
14.14
Quantity 1,780 -1.0%
Value US$25,169
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
14.27
Quantity 1,780
Value US$25,401
2.8
Jones Jeffrey Alan Chief Medical Officer Officer
Transaction date
Sale
Price
14.47
Quantity 4,582 -2.8%
Value US$66,302
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Sale
Price
14.47
Quantity 3,601 -2.0%
Value US$52,106
2.4
AHMED NADIM President and CEO Executive Director
Transaction date
Sale
Price
14.47
Quantity 13,515 -3.3%
Value US$195,562
3.0
SUMER JACQUELYN L Chief Legal Officer Officer
Transaction date
Sale
Price
14.47
Quantity 3,601 -2.7%
Value US$52,106
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,752 -1.0%
Value US$24,510
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
13.65
Quantity 1,752
Value US$23,915
1.5
Fenton Mary Kay Chief Financial Officer Officer
Transaction date
Sale
Price
13.62
Quantity 4,398 -3.4%
Value US$59,901
2.4
AHMED NADIM President and CEO Executive Director
Transaction date
Sale
Price
13.62
Quantity 16,381 -3.9%
Value US$223,109
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
14.30
Quantity 8,000 -4.2%
Value US$114,400
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Sale
Price
13.62
Quantity 3,742 -2.0%
Value US$50,966
3.0
SUMER JACQUELYN L Chief Legal Officer Officer
Transaction date
Sale
Price
13.62
Quantity 3,742 -2.8%
Value US$50,966
2.8
Jones Jeffrey Alan Chief Medical Officer Officer
Transaction date
Sale
Price
13.62
Quantity 4,982 -2.9%
Value US$67,855
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
13.88
Quantity 8,000
Value US$111,040
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Sale
Price
12.03
Quantity 416 -0.3%
Value US$5,004
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.30
Quantity 4,000 -3.0%
Value US$49,200
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
11.60
Quantity 4,000
Value US$46,400
2.4
AHMED NADIM President and CEO Executive Director
Transaction date
Sale
Price
10.01
Quantity 9,922 -2.3%
Value US$99,319
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
10.01
Quantity 1,345 -1.0%
Value US$13,463
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
9.98
Quantity 1,345
Value US$13,423
2.8
Jones Jeffrey Alan Chief Medical Officer Officer
Transaction date
Sale
Price
9.67
Quantity 4,632 -2.7%
Value US$44,791
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Sale
Price
9.67
Quantity 2,898 -2.1%
Value US$28,024
3.0
SUMER JACQUELYN L Chief Legal Officer Officer
Transaction date
Planned sale
Price
9.67
Quantity 3,480 -2.5%
Value US$33,652
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
11.90
Quantity 995 -0.7%
Value US$11,840
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
11.92
Quantity 995
Value US$11,860
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.38
Quantity 2,148 -1.5%
Value US$26,592
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.30
Quantity 4,000 -2.8%
Value US$49,200
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
9.47
Quantity 4,000
Value US$37,880
2.4
AHMED NADIM President and CEO Executive Director
Transaction date
Sale
Price
8.53
Quantity 12,529 -2.8%
Value US$106,872
2.8
Jones Jeffrey Alan Chief Medical Officer Officer
Transaction date
Sale
Price
8.53
Quantity 4,895 -2.7%
Value US$41,754
3.0
SUMER JACQUELYN L Chief Legal Officer Officer
Transaction date
Sale
Price
8.53
Quantity 3,756 -2.7%
Value US$32,039
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Sale
Price
8.53
Quantity 3,756 -2.6%
Value US$32,039
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.51
Quantity 4,000 -4.0%
Value US$50,040
3.1
JENNIFER MICHAELSON Officer Officer
Transaction date
Proposed sale
Price
12.68
Quantity 8,000
Value US$101,440
2.4
AHMED NADIM President and CEO Executive Director
Transaction date
Sale
Price
11.87
Quantity 8,400 -3.1%
Value US$99,708
3.0
SUMER JACQUELYN L Chief Legal Officer Officer
Transaction date
Sale
Price
11.41
Quantity 3,482 -3.7%
Value US$39,730
2.8
Jones Jeffrey Alan Chief Medical Officer Officer
Transaction date
Sale
Price
11.41
Quantity 4,632 -3.9%
Value US$52,851
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Sale
Price
11.41
Quantity 4,693 -4.5%
Value US$53,547
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Sale
Price
12.52
Quantity 3,489 -3.2%
Value US$43,682
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.64
Quantity 8,000 -6.9%
Value US$125,120
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.09
Quantity 8,000 -6.5%
Value US$144,720
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
16.33
Quantity 8,000 -6.1%
Value US$130,640
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
30.06
Quantity 5,606 -4.1%
Value US$168,516
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
28.54
Quantity 20,277 -13.5%
Value US$578,706
3.1
Michaelson Jennifer Chief Scientific Officer Officer
Transaction date
Planned sale
Price
27.82
Quantity 37,723 -20.1%
Value US$1,049,454
Savill Corrine Chief Business Officer Officer
Transaction date
Planned sale
Price
16.18
Quantity 40,000 -19.4%
Value US$647,200
CORINNE SAVILL Officer Officer
Transaction date
Proposed sale
Price
15.14
Quantity 40,000
Value US$605,600
Savill Corrine Chief Business Officer Officer
Transaction date
Planned sale
Price
14.09
Quantity 40,000 -19.4%
Value US$563,600
CORINNE SAVILL Officer Officer
Transaction date
Proposed sale
Price
13.07
Quantity 40,000
Value US$522,800
Savill Corrine Chief Business Officer Officer
Transaction date
Planned sale
Price
12.46
Quantity 21,316 -11.4%
Value US$265,597
Savill Corrine Chief Business Officer Officer
Transaction date
Planned sale
Price
12.02
Quantity 4,125 -2.4%
Value US$49,582
Savill Corrine Chief Business Officer Officer
Transaction date
Planned sale
Price
12.18
Quantity 14,559 -7.9%
Value US$177,329
CORINNE SAVILL Officer Officer
Transaction date
Proposed sale
Price
11.51
Quantity 40,000
Value US$460,400
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-14 2026-08-13 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
14,613 -1.3%
452.08
US$4,541,010 		14,613 -1.3% 452.08 US$4,541,010
2026-08-13 2026-08-13 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
32,417
358.87
US$1,892,626 		32,417 358.87 US$1,892,626
2026-07-07 2026-07-06 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
11,895 +34.6%
205.72
US$3,757,278 		11,895 +34.6% 205.72 US$3,757,278
2026-07-07 2026-07-06 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
8,000 -4.7%
17.82
US$142,560 		8,000 -4.7% 17.82 US$142,560
2026-07-06 2026-07-06 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
8,000
17.63
US$141,040 		8,000 17.63 US$141,040
2026-05-06 2026-05-05 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
200 -0.1%
15.58
US$3,116 		200 -0.1% 15.58 US$3,116
2026-05-06 2026-05-05 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
7,800 -4.5%
14.60
US$113,880 		7,800 -4.5% 14.60 US$113,880
2026-05-05 2026-05-05 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
8,000
15.34
US$122,720 		8,000 15.34 US$122,720
2026-03-09 2026-03-05 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
8,000 -4.5%
15.68
US$125,440 		8,000 -4.5% 15.68 US$125,440
2026-03-05 2026-03-05 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
8,000
16.30
US$130,400 		8,000 16.30 US$130,400
2026-02-26 2026-02-25 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
1,780 -1.0%
14.14
US$25,169 		1,780 -1.0% 14.14 US$25,169
2026-02-25 2026-02-25 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
1,780
14.27
US$25,401 		1,780 14.27 US$25,401
2026-02-25 2026-02-24 S Sale
2.8
Jones Jeffrey Alan

Chief Medical Officer

Officer
4,582 -2.8%
14.47
US$66,302 		4,582 -2.8% 14.47 US$66,302
2026-02-25 2026-02-24 S Sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
3,601 -2.0%
14.47
US$52,106 		3,601 -2.0% 14.47 US$52,106
2026-02-25 2026-02-24 S Sale
2.4
AHMED NADIM

President and CEO

Executive Director
13,515 -3.3%
14.47
US$195,562 		13,515 -3.3% 14.47 US$195,562
2026-02-25 2026-02-24 S Sale
3.0
SUMER JACQUELYN L

Chief Legal Officer

Officer
3,601 -2.7%
14.47
US$52,106 		3,601 -2.7% 14.47 US$52,106
2026-02-25 2026-02-23 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
1,752 -1.0%
13.99
US$24,510 		1,752 -1.0% 13.99 US$24,510
2026-02-23 2026-02-23 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
1,752
13.65
US$23,915 		1,752 13.65 US$23,915
2026-02-23 2026-02-20 S Sale
1.5
Fenton Mary Kay

Chief Financial Officer

Officer
4,398 -3.4%
13.62
US$59,901 		4,398 -3.4% 13.62 US$59,901
2026-02-23 2026-02-20 S Sale
2.4
AHMED NADIM

President and CEO

Executive Director
16,381 -3.9%
13.62
US$223,109 		16,381 -3.9% 13.62 US$223,109
2026-02-23 2026-02-20 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
8,000 -4.2%
14.30
US$114,400 		8,000 -4.2% 14.30 US$114,400
2026-02-23 2026-02-20 S Sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
3,742 -2.0%
13.62
US$50,966 		3,742 -2.0% 13.62 US$50,966
2026-02-23 2026-02-20 S Sale
3.0
SUMER JACQUELYN L

Chief Legal Officer

Officer
3,742 -2.8%
13.62
US$50,966 		3,742 -2.8% 13.62 US$50,966
2026-02-23 2026-02-20 S Sale
2.8
Jones Jeffrey Alan

Chief Medical Officer

Officer
4,982 -2.9%
13.62
US$67,855 		4,982 -2.9% 13.62 US$67,855
2026-02-20 2026-02-20 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
8,000
13.88
US$111,040 		8,000 13.88 US$111,040
2026-02-13 2026-02-12 S Sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
416 -0.3%
12.03
US$5,004 		416 -0.3% 12.03 US$5,004
2026-01-23 2026-01-22 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
4,000 -3.0%
12.30
US$49,200 		4,000 -3.0% 12.30 US$49,200
2026-01-22 2026-01-22 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
4,000
11.60
US$46,400 		4,000 11.60 US$46,400
2025-12-29 2025-12-23 S Sale
2.4
AHMED NADIM

President and CEO

Executive Director
9,922 -2.3%
10.01
US$99,319 		9,922 -2.3% 10.01 US$99,319
2025-12-22 2025-12-19 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
1,345 -1.0%
10.01
US$13,463 		1,345 -1.0% 10.01 US$13,463
2025-12-19 2025-12-19 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
1,345
9.98
US$13,423 		1,345 9.98 US$13,423
2025-12-19 2025-12-18 S Sale
2.8
Jones Jeffrey Alan

Chief Medical Officer

Officer
4,632 -2.7%
9.67
US$44,791 		4,632 -2.7% 9.67 US$44,791
2025-12-19 2025-12-18 S Sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
2,898 -2.1%
9.67
US$28,024 		2,898 -2.1% 9.67 US$28,024
2025-12-19 2025-12-18 PlS Planned sale
3.0
SUMER JACQUELYN L

Chief Legal Officer

Officer
3,480 -2.5%
9.67
US$33,652 		3,480 -2.5% 9.67 US$33,652
2025-12-16 2025-12-15 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
995 -0.7%
11.90
US$11,840 		995 -0.7% 11.90 US$11,840
2025-12-15 2025-12-15 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
995
11.92
US$11,860 		995 11.92 US$11,860
2025-12-16 2025-12-12 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
2,148 -1.5%
12.38
US$26,592 		2,148 -1.5% 12.38 US$26,592
2025-11-25 2025-11-24 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
4,000 -2.8%
12.30
US$49,200 		4,000 -2.8% 12.30 US$49,200
2025-11-24 2025-11-24 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
4,000
9.47
US$37,880 		4,000 9.47 US$37,880
2025-10-30 2025-10-28 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
165,667 +1.9%
8.40
US$1,391,686 		165,667 +1.9% 8.40 US$1,391,686
2025-10-21 2025-10-17 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
32,217 +0.4%
7.84
US$252,565 		32,217 +0.4% 7.84 US$252,565
2025-10-21 2025-10-16 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
150,000 +1.7%
8.86
US$1,328,250 		150,000 +1.7% 8.86 US$1,328,250
2025-10-21 2025-10-15 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
51,500 +0.6%
7.94
US$409,049 		51,500 +0.6% 7.94 US$409,049
2025-10-21 2025-10-14 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
15,032 +0.2%
7.59
US$114,048 		15,032 +0.2% 7.59 US$114,048
2025-10-10 2025-10-10 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
277,298 +3.4%
7.36
US$2,041,385 		277,298 +3.4% 7.36 US$2,041,385
2025-10-10 2025-10-09 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
626,043 +8.2%
6.70
US$4,191,859 		626,043 +8.2% 6.70 US$4,191,859
2025-10-10 2025-10-08 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
556,300 +7.8%
6.46
US$3,593,698 		556,300 +7.8% 6.46 US$3,593,698
2025-02-27 2025-02-25 S Sale
2.4
AHMED NADIM

President and CEO

Executive Director
12,529 -2.8%
8.53
US$106,872 		12,529 -2.8% 8.53 US$106,872
2025-02-27 2025-02-25 S Sale
2.8
Jones Jeffrey Alan

Chief Medical Officer

Officer
4,895 -2.7%
8.53
US$41,754 		4,895 -2.7% 8.53 US$41,754
2025-02-27 2025-02-25 S Sale
3.0
SUMER JACQUELYN L

Chief Legal Officer

Officer
3,756 -2.7%
8.53
US$32,039 		3,756 -2.7% 8.53 US$32,039
2025-02-27 2025-02-25 S Sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
3,756 -2.6%
8.53
US$32,039 		3,756 -2.6% 8.53 US$32,039
2025-01-07 2025-01-06 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
4,000 -4.0%
12.51
US$50,040 		4,000 -4.0% 12.51 US$50,040
2025-01-06 2025-01-06 PrS Proposed sale
3.1
JENNIFER MICHAELSON

Officer

Officer
8,000
12.68
US$101,440 		8,000 12.68 US$101,440
2024-12-27 2024-12-24 S Sale
2.4
AHMED NADIM

President and CEO

Executive Director
8,400 -3.1%
11.87
US$99,708 		8,400 -3.1% 11.87 US$99,708
2024-12-20 2024-12-18 S Sale
3.0
SUMER JACQUELYN L

Chief Legal Officer

Officer
3,482 -3.7%
11.41
US$39,730 		3,482 -3.7% 11.41 US$39,730
2024-12-20 2024-12-18 S Sale
2.8
Jones Jeffrey Alan

Chief Medical Officer

Officer
4,632 -3.9%
11.41
US$52,851 		4,632 -3.9% 11.41 US$52,851
2024-12-20 2024-12-18 S Sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
4,693 -4.5%
11.41
US$53,547 		4,693 -4.5% 11.41 US$53,547
2024-12-16 2024-12-12 S Sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
3,489 -3.2%
12.52
US$43,682 		3,489 -3.2% 12.52 US$43,682
2024-11-07 2024-11-05 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
8,000 -6.9%
15.64
US$125,120 		8,000 -6.9% 15.64 US$125,120
2024-09-09 2024-09-05 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
8,000 -6.5%
18.09
US$144,720 		8,000 -6.5% 18.09 US$144,720
2024-09-05 2024-09-05 PrS Proposed sale
3.1
JENNIFER MICHAELSON & MARC D MICHAELSON

Officer

Officer
16,000
18.68
US$298,880 		16,000 18.68 US$298,880
2024-07-09 2024-07-05 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
8,000 -6.1%
16.33
US$130,640 		8,000 -6.1% 16.33 US$130,640
2024-07-05 2024-07-05 PrS Proposed sale
3.1
JENNIFER MICHAELSON & MARC D MICHAELSON

Officer

Officer
5,606
16.78
US$94,069 		5,606 16.78 US$94,069
2024-05-08 2024-05-07 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
5,606 -4.1%
30.06
US$168,516 		5,606 -4.1% 30.06 US$168,516
2024-05-08 2024-05-06 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
20,277 -13.5%
28.54
US$578,706 		20,277 -13.5% 28.54 US$578,706
2024-05-08 2024-05-06 PlS Planned sale
3.1
Michaelson Jennifer

Chief Scientific Officer

Officer
37,723 -20.1%
27.82
US$1,049,454 		37,723 -20.1% 27.82 US$1,049,454
2024-05-06 2024-05-06 PrS Proposed sale
3.1
JENNIFER MICHAELSON & MARC D MICHAELSON

Officer

Officer
66,000
28.35
US$1,871,100 		66,000 28.35 US$1,871,100
2024-02-02 2024-02-01 PlS Planned sale
Savill Corrine

Chief Business Officer

Officer
40,000 -19.4%
16.18
US$647,200 		40,000 -19.4% 16.18 US$647,200
2024-02-01 2024-02-01 PrS Proposed sale
CORINNE SAVILL

Officer

Officer
40,000
15.14
US$605,600 		40,000 15.14 US$605,600
2024-01-30 2024-01-29 PlS Planned sale
Savill Corrine

Chief Business Officer

Officer
40,000 -19.4%
14.09
US$563,600 		40,000 -19.4% 14.09 US$563,600
2024-01-29 2024-01-29 PrS Proposed sale
CORINNE SAVILL

Officer

Officer
40,000
13.07
US$522,800 		40,000 13.07 US$522,800
2024-01-24 2024-01-23 PlS Planned sale
Savill Corrine

Chief Business Officer

Officer
21,316 -11.4%
12.46
US$265,597 		21,316 -11.4% 12.46 US$265,597
2024-01-24 2024-01-22 PlS Planned sale
Savill Corrine

Chief Business Officer

Officer
4,125 -2.4%
12.02
US$49,582 		4,125 -2.4% 12.02 US$49,582
2024-01-24 2024-01-22 PlS Planned sale
Savill Corrine

Chief Business Officer

Officer
14,559 -7.9%
12.18
US$177,329 		14,559 -7.9% 12.18 US$177,329
2024-01-22 2024-01-22 PrS Proposed sale
CORINNE SAVILL

Officer

Officer
40,000
11.51
US$460,400 		40,000 11.51 US$460,400
Explore more

More insider trading research around Cullinan Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America